Showing results (171-180 of 184) with videos related to
Sort By:
Pageof 19
Plos One|July 19, 2012
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CChristian M Lange, Stephanie Bibert, Zoltan Kutalik, et al.Nature Communications|October 13, 2024
HEV ORF2 protein-antibody complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune statusAnne-Laure Leblond, Birgit Helmchen, Maliki Ankavay, et al.Nature Communications|December 24, 2014
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.American Journal of Human Genetics|May 15, 2024
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variationZhi Ming Xu, Gnimah Eva Gnouamozi, Sina Rüeger, et al.Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.Expert Review of Anti-Infective Therapy|November 8, 2016
A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosisSylvain Ambregna, Stéphane Koch, Michael C Sulz, et al.Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.Oncotarget|October 4, 2017
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver diseaseAbderrahim Oussalah, Patrice Hodonou Avogbe, Erwan Guyot, et al.Pageof 19